APA (7th ed.) Citation

Sinnadurai, M., & McDonald, K. L. (2017). Immune checkpoint inhibition and its relationship with hypermutation phenoytype as a potential treatment for Glioblastoma. Journal of Neuro-Oncology, 132(3), 359-372. https://doi.org/10.1007/s11060-017-2390-3

Chicago Style (17th ed.) Citation

Sinnadurai, Manohan, and Kerrie L. McDonald. "Immune Checkpoint Inhibition and Its Relationship with Hypermutation Phenoytype as a Potential Treatment for Glioblastoma." Journal of Neuro-Oncology 132, no. 3 (2017): 359-372. https://doi.org/10.1007/s11060-017-2390-3.

MLA (9th ed.) Citation

Sinnadurai, Manohan, and Kerrie L. McDonald. "Immune Checkpoint Inhibition and Its Relationship with Hypermutation Phenoytype as a Potential Treatment for Glioblastoma." Journal of Neuro-Oncology, vol. 132, no. 3, 2017, pp. 359-372, https://doi.org/10.1007/s11060-017-2390-3.